Stuart Charney

Co-founder, Managing Partner @Sixdegrees Health Care Consulting

Embedded the Patient Voice Across the Product Lifecycle: Designed cross-functional advocacy strategies integrating patient perspectives into R&D, clinical trial design, and access pathways—focused on advanced therapies, biomarkers, and diagnostics.Led 50+ Strategic Horizon Scans: Informed client resource deployment, stakeholder engagement, and narrative development by overseeing targeted policy and pipeline scans.Elevated National Advocacy Capabilities: Transformed engagement, collaboration, and communications for dozens of national patient and professional societies—aligning efforts with sponsor goals and community priorities.Pioneered Multi-Stakeholder Advocacy Platforms: Co-developed a mental health-focused social media initiative to mobilize awareness and action on access, coverage, and equity.Drove Trial Recruitment Innovation: Collaborated with advocacy organizations, academic medical centers, and state health agencies to develop patient-centric clinical trial recruitment programs for investigational drugs and vaccines.Crafted Advocacy Messaging Campaigns: Developed targeted, patient-centered communications defending access to therapies, biomarker-driven innovations, and Medicaid eligibility.Built Policy Advocacy Capacity: Created and led educational workshops enabling patient groups to influence health policy through state advisory councils and Medicaid MCO boards.Mobilized National Stakeholders on Policy Reform: Convened national and state advocacy organizations to shape comparative and cost-effectiveness policy at CMS, ICER, and PCORI.Directed High-Impact Coalitions: Organized and led national/state alliances to prevent restrictive reimbursement mandates—protecting clinical integrity and patient access.Led Industry-Academic Engagement Strategy: For over a decade, directed a major trade association’s outreach to medical societies and academic institutions to build legislative and regulatory support around coverage, reimbursement, and innovation.